Search

everythinglearnresearchcommunity

for

Search:↓

Quercetin effectively treated and prevented hair loss in mice.

The combined therapy was effective and safe for children with severe alopecia areata.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Vitamin D levels do not affect the risk of developing alopecia areata.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Topical immunotherapy is the best treatment for severe alopecia areata.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Yellow dots are common in severe alopecia areata.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.